CPR returned as a corporate sponsor for the One-North Run 2016 which was jointly organized by A*STAR, JTC and Mediacorp. As the funds raised from the Run go directly to the Singapore Children’s Society and Community Chest, we are honored to be invited to the event which gave us the opportunity to give back to the society and play a part in local community. Our participation clearly showed that we are adhering to the Chugai Group’s mission of creating innovative medical products and services for the benefit of the medical community and human health around the world. As one of participants commented, “I am glad to join this charity event as a society member.” (Photo: employees with the finisher medal.)
CPR commemorated its 5th anniversary of foundation by holding a reception and dinner at Ritz Carlton Hotel on November 14. At the welcome address, Mr. Osamu Nagayama, Chairman and CEO of Chugai Pharmaceutical extended sincere gratitude to all business partners for their invaluable support for Chugai and CPR. Messages from the distinguished guests, Dr. Beh Swan Gin, Chairman of EDB, Mr. Lim Chuan Poh, Chairman of A*STAR and Mr. Kenji Shinoda, Ambassador of Japan to Singapore encouraged us to further dedicate ourselves to develop new innovative antibody drugs. We are confident in our ability to continue contributing to the dynamic research environment here in Singapore.
The 4th antibody symposium, co-organized by p53 Laboratory, A*STAR Biomedical Sciences Institutes and CPR, was held at Matrix, Biopolis with around 300 audiences. The symposium commenced with an opening address from Mr. Osamu Nagayama, Chairman and CEO of Chugai Pharmaceutical, followed by keynote lectures from Dr. Mark Davis, Stanford University and Prof. Tomohiro Kurosaki, Osaka University IFReC. Dr. Nezu, CPR Research Head, also showed the successful development of bispecific antibody project. CPR is honored to help provide scientists in Biopolis with cutting-edge antibody researches and encourage interaction among government, academia and industry. (Photo: Mr. Nagayama, Chairman and CEO of Chugai)
The One-North Run 2015, co-organized by the Agency for Science, Technology and Research (A*STAR) and the JTC Corporation, was held at One-North Park: Mediapolis. This inaugural event is to show the One-North community’s physical display of unity for a charitable cause to raise donation for the less fortunate in Singapore. CPR, in sympathy with the purposes, sponsored the event as a part of its social contribution activities and over 30 members including CEO Dr. Matsubara participated in the run. In addition to its corporate mission to create innovative medical products and services for the benefit of the medical community and human health around the world, we are proud to be involved in contribution to the local community. (Photo: Dr. Matsubara and other employees after finishing the run.)
The 3rd antibody symposium, co-organized by p53 Laboratory, A*STAR Biomedical Sciences Institutes and Chugai Pharmabody Research, was held in Biopolis, Singapore. The symposium serves to provide a platform for scientists to share cutting-edge antibody researches conducted within A*STAR, the universities and industries in Biopolis. At the opening address, guest of honour, Mr. Lim Chuan Poh, Chairman of A*STAR, expressed his appreciations to Chugai which had started its research operations in Singapore since 2002. The symposium commenced with a keynote lecture from Dr. Arnold Levine, CPR Director and Emeritus Professor, Institute for Advanced Study. On this opportunity, five scientists from CPR introduced their effective antibody drug discovery processes.
The annual BioPharma Asia Convention is the leading event for Asia’s biopharma industry. This year marks the 7th, and it was held in Suntec Singapore International Convention & Exhibition Centre from 10th Mar to 13th Mar. The purpose of this convention is to bring together decision makers and influentials from the pharma and biotech industries, academia, CROs as well as CMOs, as it delivers an unparalleled opportunity to convene, network and deliberate. CPR was invited as a speaker to present our latest antibody production platform. Approaches to overcome the bottlenecks of antibody production in early-stage R&D were discussed.
CPR is proud to join Biopolis in its 10th anniversary celebrations by taking up a booth to showcase our company activities at the Biopolis Carnival. At the booth, we had the opportunity to converse with over 800 visitors as we presented them with our antibody-shaped balloons. Since Chugai’s first satellite lab (PharmaLogicals Research) commenced its operations here in Singapore in 2002, and later, CPR in 2012, it has been playing a key role in the area of research of pharmaceutical business by utilizing Singapore’s Biomedical Sciences environment to its advantage. It is a great honour for us to be marked in Biopolis’s glorious history and we further strive to achieve our goals to create innovative antibody drugs that can address unmet medical needs.
The 2nd antibody symposium, co-organized by p53 Laboratory, A*STAR Biomedical Sciences Institutes and Chugai Pharmabody Research, was held in Biopolis, Singapore. At the symposium, a total of 11 scientists presented with updates of innovative antibody research that have since been conducted in A*STAR, the academia and the pharma industry to foster greater interaction. Following the brief overview of antibody drug discovery in Chugai and CPR by Dr. Nezu, Research Head of CPR, 4 scientists from Chugai and CPR had the privilege to introduce their innovative antibody technologies. They also took the opportunity to outline several research projects which Chugai and CPR are currently developing. (Photo: Mr. Zenjiro Sampei, Researcher of CPR)
CPR commemorated its 1st anniversary of operations by holding a reception and dinner with 60 guests at Raffles Hotel on June 27. Among the distinguished guests who came to congratulate Chugai on the success of CPR and offer their best wishes for the future were Mr. Philip Yeo, Chairman of SPRING Singapore, and Mr. Yoichi Suzuki, Japanese Ambassador to Singapore. With deep gratitude to all of our business partners for their tremendous support, CPR will endeavour with single-minded dedication to further accelerate the generation of innovative antibody drugs over the coming years in order to address unmet medical needs.
A presentation to explain CPR’s proprietary antibody engineering technology, Recycling & Sweeping antibody technology, was given at Drug Discovery World Asia 2013 by CPR’s Research Head Dr Junichi Nezu. The symposium was held in conjunction with the 6th Annual BioPharma Asia Convention 2013 from 19-20 March 2013 at Resorts World Convention Center, Sentosa, Singapore. Biopharma Asia Convention 2013 is known as Asia’s largest biopharmaceutical industry gathering, focusing on innovation and strategies for pharmas, biotechs and the R&D community.
|November 27, 2016||One-North Run 2016|
|November 14, 2016||CPR’s 5th Anniversary Party|
|November 14, 2016||4th Antibody Symposium in Biopolis, Singapore|
|November 29, 2015||One-North Run 2015|
|January 14, 2015||3rd Antibody Symposium in Biopolis, Singapore|
|March 10-13, 2014||BioPharma Asia Convention 2014|
|October 18, 2013||Biopolis 10th Anniversary Carnival|
|September 10, 2013||2nd Antibody Symposium in Biopolis, Singapore|
|June 27, 2013||CPR’s 1st Anniversary Party|
|March 19, 2013||BioPharma Asia Convention 2013|